...
首页> 外文期刊>Journal of genetic counseling >Patients’ Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease Carriers
【24h】

Patients’ Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease Carriers

机译:患者对遗传疾病携带者帕金森病风险增加的遗传咨询观

获取原文
获取原文并翻译 | 示例
           

摘要

Gaucher disease (GD) is an autosomal recessive disease caused by GBA mutations that is especially common in the Ashkenazi Jewish (AJ) population. The link between GBA mutations and Parkinson disease (PD), a later-onset neurodegenerative condition, is well established, and studies have shown that GBA carriers have an increased lifetime risk of developing PD. Carrier screening for GD is frequently offered to couples during or prior to pregnancy, especially to those of AJ descent. However, no studies have been performed to assess if prospective parents would want to learn about their risk of developing PD incidentally through carrier screening. It is also unknown if pre-test counseling on this topic would affect screening uptake. In order to answer these questions, a survey was administered to individuals who screened negative for GBA mutations. Of the 75 participants, 86.7% believed that patients should be informed about the increased risk of PD prior to having GD carrier screening, and 93.3% responded that this information would not have changed their decision to have carrier screening. These results indicate that healthcare providers should take into consideration patient preferences when determining how to counsel about GD carrier screening. Additionally, these results have implications for genetic counseling about other later-onset conditions that may be incidentally ascertained through carrier screening.
机译:Gaucher疾病(GD)是由GBA突变引起的常染色体隐性疾病,这些突变在阿什妥妥犹太人(AJ)人群中特别常见。 GBA突变与帕金森病(Pd)之间的联系,一种良好的神经变性病症,已经确定,并且研究表明,GBA载体具有增加的开发PD的寿命风险。对于GD的载体筛选经常在怀孕期间或之前对夫妻提供,尤其是AJ血统的夫妻。但是,如果未来的父母希望通过载体筛查偶然地了解其偶然发展PD的风险,则没有进行研究。如果对本主题的预先测试咨询会影响筛选摄取,这也是未知的。为了回答这些问题,向筛选GBA突变的个体进行调查。在75名参与者中,86.7%相信患者应在拥有GD载体筛查之前了解PD的风险增加,93.3%的回答说,这些信息不会改变他们的决定具有载体筛查。这些结果表明,医疗保健提供者应在确定关于GD载体筛查的咨询时考虑患者偏好。另外,这些结果对遗传咨询有关其他以载体筛选可以确定的其他后发病条件的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号